BIOCRYST PHARMACEUTICALS INC. - COMMON STOCK
7.6950
14-November-24 09:53:51
15 minutes delayed
Stocks
+0.0550
+0.72%
Today's range
7.5500 - 7.7400
ISIN
N/A
Source
NASDAQ
-
27 Apr 2022 06:00:00 By Nasdaq GlobeNewswire
-
BioCryst to Report First Quarter 2022 Financial Results on May 5
21 Apr 2022 06:00:52 By Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conference
11 Apr 2022 07:30:49 By Nasdaq GlobeNewswire
-
BioCryst Pauses Enrollment in BCX9930 Clinical Trials
08 Apr 2022 08:15:13 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Apr 2022 06:15:42 By Nasdaq GlobeNewswire
-
BioCryst to Present at Upcoming Investor Conferences
03 Mar 2022 06:00:01 By Nasdaq GlobeNewswire
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Mar 2022 06:00:01 By Nasdaq GlobeNewswire
-
BioCryst Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Key Milestones
23 Feb 2022 06:00:01 By Nasdaq GlobeNewswire
-
BioCryst to Report Fourth Quarter 2021 Financial Results on February 23
09 Feb 2022 06:00:00 By Nasdaq GlobeNewswire